Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamol-induced hepatic necrosis

Journal of Pathology

Volumn 190, Issue 4, 2000, Pages 489-494

  Simpson, Kenneth J ^a,b   Lukacs, Nicholas W ^b   McGregor, Angus H ^c   Harrison, David J ^c   Strieter, Robert M ^d   Kunkel, Steven L ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acetaminophen; Paracetamol; Toxic liver injury; Tumour necrosis factor

Indexed keywords

ASPARTATE AMINOTRANSFERASE; DEXAMETHASONE; INTERLEUKIN 10; PARACETAMOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; ASPARTATE AMINOTRANSFERASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LIVER; MICE; MICE, INBRED CBA; NECROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034061236     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200003)190:4<489::AID-PATH534>3.0.CO;2-V     Document Type: Article

References (32)

1. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445.
2. Mitchell JR, Jollow DJ, Potter WZ, Davis D, Gillette JR, Brodie BB. Acetaminophen induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973; 187: 185-194.
3. Chanda S, Mehendale HM. Hepatic cell division and tissue repair: a key to survival after liver injury. Mol Med Today 1996; 2: 82-89.
4. Laskin DL, Gardner CR, Price VF, Jollow DJ. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 1995; 21: 1045-1050.
5. Goldin RD, Ratnayaka ID, Breach CS, Brown IN, Wickramasinghe SN. Role of macrophages in acetaminophen (paracetamol) induced hepatotoxicity. J Pathol 1996; 179: 432-435.
6. Takenaka K, Sakaida I, Yasunaga M, Okita K. Ultrastructural study of development of hepatic necrosis induced by TNF-α and D-galactosamine. Digestive Dis Sci 1998; 43: 887-892.
7. Edwards MJ, Keller BJ, Kaufman FC, Thurman RG. The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol Appl Pharmacol 1993; 119: 275-279.
8. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumour necrosis factor induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-1234.
9. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride induced rat liver injury by soluble tumour necrosis factor receptor. Gastroenterology 1995; 108: 1849-1854.
10. Kayama F, Yoshida T, Elwell MR, Luster MI. Role of tumour necrosis factor alpha in cadmium induced hepatotoxicity. Toxicol Appl Pharmacol 1995; 131: 224-234.
11. Louis H, Lemoine O, Peny MO, et al. Hepatoprotective role of inlerleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 1997; 112: 935-942.
12. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A induced T-cell mediated hepatic injury in mice: role of tumour necrosis factor. Hepatology 1995; 21: 190-198.
13. Colletti LM, Kunkel SL, Walz A, et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996; 23: 506-514.
14. Remick DG, Stricter RM, Eskandari MK, et al. Role of TNF alpha in lipopolysaccharide induced pathological alterations. Am J Pathol 1990; 136: 49-54.
15. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Anti-tumour necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 1992; 148: 2724-2730.
16. Hewett JA, Jean PA, Kunkel SL, Roth RA. Relationship between tumour necrosis factor alpha and neutrophils in endotoxin induced liver injury. Am J Physiol 1993; 265: G1011-G1015.
17. Lukacs NW, Strieter RM, Chensue SW, Widmer M, Kunkel SL. TNF alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 1995; 154: 5411-5417.
18. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. Balance of inflammatory cytokines related to the severity and mortality of murine sepsis. Infect Immun 1996; 64: 4733-4738.
19. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL. Neutralisation of IL10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein 2 and tumour necrosis factor. J Immunol 1995; 155: 2222-2229.
20. Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin 1 alpha, beta and tumour necrosis factor during experimental endotoxemia: kinetics, Kupffer cell expression and glucocorticoid effects. Am J Pathol 1991; 138: 395-402.
21. Devictor D, Decimo D, Sebire G, Tardieu M, Hadchouel M. Enhanced tumour necrosis factor alpha in coronavirus but not in paracetamol-induced acute hepatic necrosis in mice. Liver 1992; 12: 205-208.
22. Boess F, Bopst M, Althaus R, et al. Acetaminophen hepatotoxicity in tumour necrosis factor/lymphotaxin-α gene knockout mice. Hepatology 1998; 27: 1021-1029.
23. Ramadori G, Armbrust T. Cytokines. In Liver Growth and Repair (1st edn), Strain AJ, Diehl AM (eds). Chapman & Hall: London; 1998; 283-294.
24. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 1995; 133: 43-52.
25. Tsutsui H, Matsui K, Kawada N, et al. IL-18 accounts for both TNF-alpha- and fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997; 159: 3961-3967.
26. Santucci L, Fiorucci S, Chiorean M, et al. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine sensitised mice. Gastroenterology 1996; 111: 736-744.
27. Kimura T, Sakaida I, Terai S, Matsumura Y, Uchida K, Okita K. Inhibition of tumour necrosis factor-alpha production retards liver regeneration after partial hepatectomy in rats. Biochem Biophys Res Commun 1997; 231: 557-560.
28. Bemelmans MH, van Tits LJ, Buurman WA. Tumour necrosis factor: function, release and clearance. Crit Rev Immunol 1996; 16: 1-11.
29. Blazka ME, Elwell MR, Holladay SD, Wilson RE, Luster MI. Histopathology of acetaminophen induced liver changes: role of interleukin 1 alpha and tumour necrosis factor alpha. Toxicol Pathol 1996; 24: 181-189.
30. Suzuki S, Nakamura S, Serizawa A. et al. Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomy. Hepatology 1996; 24: 219-225.
31. Bathe OF, Chow AW, Phang PT. Splanchnic origin of cytokines in a porcine model of ischaemia reperfusion. Surgery 1997; 123: 79-88.
32. Bruccoleri A, Gallucci R, Germolec DR, et al. Induction of early immediate genes by tumour necrosis factor alpha contributes to liver repair following chemical induced hepatotoxicity. Hepatology 1997; 25: 133-141.